摘要:The delivery of docosahexanoic acid (DHA) to the fetus is dependent on maternal one-carbon metabolism, as the latter supports the hepatic synthesis and export of a DHA-enriched phosphatidylcholine molecule via the phosphatidylethanolamine
N-methyltransferase (PEMT) pathway. The following is a post-hoc analysis of a choline intervention study that sought to investigate whether common variants in one-carbon metabolizing genes associate with maternal and/or fetal blood biomarkers of DHA status. Pregnant women entering their second trimester were randomized to consume, until delivery, either 25 (
n = 15) or 550 (
n = 15) mg choline/d, and the effects of genetic variants in the
PEMT,
BHMT,
MTHFD1, and
MTHFR genes on DHA status were examined. Variant (vs. non-variant) maternal
PEMT rs4646343 genotypes tended to have lower maternal RBC DHA (% total fatty acids) throughout gestation (6.9% vs. 7.4%; main effect,
p = 0.08) and lower cord RBC DHA at delivery (7.6% vs. 8.4%; main effect,
p = 0.09). Conversely, variant (vs. non-variant) maternal
MTHFD1 rs2235226 genotypes exhibited higher cord RBC DHA (8.3% vs. 7.3%; main effect,
p = 0.0003) and higher cord plasma DHA (55 vs. 41 μg/mL; main effect,
p = 0.05). Genotype tended to interact with maternal choline intake (
p < 0.1) to influence newborn DHA status for
PEMT rs4646343 and
PEMT rs7946. These data support the need to consider variants in one-carbon metabolic genes in studies assessing DHA status and requirements during pregnancy.